SCHEMBL4430210

SCHEMBL4430210

[CH2]C(O)(CC(C)(C)c1cccc(OC)c1)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
CCR6 P51684 1/20 0.41
KCNH2 Q12809 1/20 0.41
NR3C2 P08235 1/20 0.39
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RORA P35398 1/20 0.38
RORC P51449 1/20 0.38
NR1H2 P55055 1/20 0.38
KIF11 P52732 1/20 0.38
ALDH1A1 P00352 2/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
CYP3A4 P08684 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14158802 0.86 L3MBTL1 (0.45) PDK2KDM4EALDH1A1CYP3A4MAPT
SCHEMBL4437949 0.85 PTPN5 (0.41) PDK2CCR6KDM4EMEN1KMT2A
SCHEMBL4452422 0.81 NR3C1 (0.49) NR3C2KIF11CYP3A4HDAC6
SCHEMBL27650712 0.80 PDK1 (0.43) PDK1PDK2PDK3PDK4CCR6
SCHEMBL27756725 0.78 CCR6 (0.45) PDK1PDK2PDK3PDK4CCR6
SCHEMBL4430202 0.78 TAAR1 (0.44) PDK1PDK2PDK3PDK4NR3C2
SCHEMBL23838094 0.77 HSD11B1 (0.50) PDK1PDK2PDK3PDK4CCR6
SCHEMBL21087697 0.77 HSD11B1 (0.50) PDK1PDK2PDK3PDK4CCR6
SCHEMBL3679775 0.77 NPSR1 (0.37) NR3C2MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8705771 0.76 KIF11 (0.46) PDK1PDK2PDK3PDK4KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012170175-A1 COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, OR AMELIORATING INFLAMMATORY PAIN BAUSCH & LOMB INCORPORATED (US) 2012-12-13 WO disclosed
EP-2061444-A2 COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, AMELIORATING, OR PREVENTING ALLERGY Bausch & Lomb Incorporated (US) 2009-05-27 EP disclosed
EP-2056799-A2 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GLAUCOMA OR PROGRESSION THEREOF Bausch & Lomb Incorporated (US) 2009-05-13 EP disclosed
WO-2008033655-A2 COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, AMELIORATING, OR PREVENTING ALLERGY BAUSCH & LOMB INCORPORATED (US) 2008-03-20 WO disclosed
WO-2008027796-A2 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GLAUCOMA OR PROGRESSION THEREOF BAUSCH & LOMB INCORPORATED (US) 2008-03-06 WO disclosed